Akoya BioSciences, Inc. - stock earnings
AKYA Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -10.8 million USD | 26.5 million USD |
2023Q3 | -12.9 million USD | 25.2 million USD |
2023Q2 | -20.8 million USD | 23.5 million USD |
2023Q1 | -18.8 million USD | 21.4 million USD |
2022Q4 | -18.9 million USD | 21.2 million USD |
2022Q3 | -17.9 million USD | 18.9 million USD |
2022Q2 | -17.5 million USD | 17.9 million USD |
2022Q1 | -16.4 million USD | 16.9 million USD |
2021Q4 | -17.7 million USD | 16.2 million USD |
2021Q3 | -11.6 million USD | 13.5 million USD |
2021Q2 | -5.6 million USD | 13.1 million USD |
2021Q1 | -8.1 million USD | 12.2 million USD |
2020Q4 | -5.7 million USD | 12.9 million USD |
2020Q3 | -4.3 million USD | 10.0 million USD |
2020Q2 | -4.6 million USD | 8.6 million USD |
2020Q1 | -2.1 million USD | 11.0 million USD |
AKYA Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -63.3 million USD | 96.6 million USD |
2022 | -70.6 million USD | 74.9 million USD |
2021 | -42.9 million USD | 54.9 million USD |
2020 | -16.7 million USD | 42.4 million USD |
2019 | -14.8 million USD | 42.2 million USD |
AKYA
Price: $4.04
52 week price:
Earnings Per Share: -1.43 USD
P/E Ratio: -3.46
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 51598
Market Capitalization: 203.0 million